Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Canadian Banc Corp. Announces TSX Acceptance of Normal Course Issuer Bid
-
Dividend 15 Split Corp. II Announces TSX Acceptance of Normal Course Issuer Bid
-
SL Green Announces the Sale of 10 East 53rd Street
-
Belo Sun Announces Corporate Update
-
Generali Expands Deployment of Intermap's AI-Enabled Risk Platform in Central and Eastern Europe
-
Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026
-
DEEP SEA MINERALS CORP. ACHIEVES SUBSTANTIAL COMPLIANCE DETERMINATION FROM NOAA UNDER DSHMRA FOR SEABED MINERAL CONCESSIONS
-
Anterix Sets Fourth Quarter Fiscal 2026 Earnings Conference Call for Thursday, June 11, at 9:00 a.m. ET
-
Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001
-
XCharge Appoints Albina Iljasov as Co-Chief Executive Officer
-
TechForce Robotics Enters Pharmaceutical Automation Market Through Initial Deployment at Oncotelic Therapeutics
-
BriaCell Presents Positive Clinical Data at ASCO 2026
-
HCI Group Announces Completion of its 2026-2027 Catastrophe Reinsurance Programs
-
Athene Announces Key Leadership Appointment
-
Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO
-
Vireo Growth Inc. Announces Share Consolidation
-
Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
Mattr Appoints New Director
-
Generali Expands Deployment of Intermap's AI-Enabled Risk Platform in Central and Eastern Europe
-
Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany
-
Otherwander Opens in the Heart of Soho, London
-
Canadian Author Grows Hope with the Launch of Don't Let Ned Plant a Tree THERE! on International Children's Day
-
Canadian Author Grows Hope with the Launch of Don't Let Ned Plant a Tree THERE! on International Children's Day
-
Ninth Circuit Anticipated to Rule on UnitedHealthcare’s Alleged Deceptive Medicare Advantage Advertising Practices - GJLaw
-
FLUENT Reports First Quarter 2026 Results
-
New Era Energy & Digital Announces Upcoming Conference Participation and Expected Russell Index Inclusion
-
New Era Energy & Digital Announces Upcoming Conference Participation and Expected Russell Index Inclusion
-
Edible Garden Accelerates Path to Profitability Through Major Logistics Transformation, Reducing Operating Costs, Lowering Emissions and Enhancing Supply Chain Efficiency
-
Novo Nordisk A/S - share repurchase programme
-
DELPHX ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE
-
Richardson Hartley Law and Humphries Kerstetter to pursue Meta for role in multi-billion scam ad scandal through group legal action
-
Scemblix® continued to show superior efficacy and favorable safety and tolerability profile at week 144 in newly diagnosed CML
-
Piedmont REIT Signs 240,000 SF of Leases Second Quarter-to-Date Bringing YTD Leasing to approximately 670,000 SF
-
Piedmont REIT Signs 240,000 SF of Leases Second Quarter-to-Date Bringing YTD Leasing to approximately 670,000 SF
-
Crypto News: Gruntle Confirms Round 7 Presale Closes June 4 as CFTC Greenlights First Regulated Bitcoin Perpetual Futures
-
IREN Closes $3.65bn Investment-Grade GPU Financing
-
NEURONES: Declaration of transactions on treasury shares (May 25 to 29, 2026)
-
SAIC Announces First Quarter of Fiscal Year 2027 Results
-
Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
-
Anfield Energy Inc. Completes Phase One Surface Construction at Velvet-Wood Project
-
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
-
Lithium Ionic Provides Bi-Weekly MCTO Status Update
-
TDG Initiates Preliminary Economic Assessment for the Shasta Gold-Silver Project
-
Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer
-
REV Closes $4 Million Private Placement with Eric Sprott to Accelerate Helium and Natural Hydrogen Exploration and Drill Programs
-
NexGold Advancing Key Development Activities on Schedule at the Goldboro Gold Project in Nova Scotia
-
Lantronix Launches SLC 9000 to Secure AI Data Centers and Mission-Critical Networks at Scale
-
Moisson Montréal launches Hungry for Vacation
-
Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
